SEC Form 4 · accession 0001651844-15-000010
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Dec 28, 2015
Accepted (ET)
Dec 30, 2015 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 28, 2015 | P | 6,000 | $3.79 | A | 2,523,550 | D | |
| Common Stock | Dec 29, 2015 | P | 14,000 | $3.55 | A | 2,537,550 | D | |
| Common Stock | Dec 30, 2015 | P | 5,000 | $3.38 | A | 2,542,550 | D | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.